UnknownPhase 1/2

MSCs for the Treatment of Burn Wounds

Venezuela50 participantsStarted 2021-06-30

Plain-language summary

The goal of this study is to evaluate the capacity of allogenic mesenchymal stromal cells form bone marrow (BM-MSC) or adipose tissue(Ad-MSC) to induce wound healing in patients with burn wounds.

Who can participate

Age range2 Weeks – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 2 weeks and 85 years old * Patient with second- or third-degree burn (AB/B or B). * Thermal burns * Electrical burns * Chemical burns * Informed consent of the patient or caretaker Exclusion Criteria: * First degree burn (A or AB) * Evidence of active infection at the wound site * Chronic malnutrition * Systemic inflammatory response syndrome (SIRS) or sepsis * Moderate or severe respiratory tract or lungs burn injuries * Autoimmune disease (e.g. multiple sclerosis, lupus erythematosus) * Severe pulmonary disease, hematologic disease, malignancy, or hypo-immunity. * Diabetes * Pregnancy

What they're measuring

Re-epithelialization areas

Timeframe: Up to 6 month

Complete burn wound healing

Timeframe: Up to 12 month

Trial details

NCT IDNCT06103409

SponsorInstituto Venezolano de Investigaciones Cientificas

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-30

View on ClinicalTrials.gov More Burn Wound trials